KDP - Educational Analysis * US Equities
Educational Analysis * US Equities

KDP

Earnings behavior, post-earnings drift, and the gap between consensus and the market's real expectation - the educational primer before you look at the institutional verdict.

Educational content only - not investment advice. Nothing on this page is a recommendation to buy or sell any security. Historical patterns do not predict future outcomes. Consult a licensed financial advisor before making any trading decision.
Published byGamma QC editorial
TickerKDP
CategoryEducational primer
Last reviewedNovember 2, 2026
You're viewing an older edition of this page.Read the latest edition →

Business profile & competitive position

Keurig Dr Pepper Inc. is classified as a Consumer Defensive / Beverages – Non-Alcoholic company. It manufactures, markets, distributes, and sells hot and cold beverages and single-serve brewing systems across more than 125 owned, licensed, and partner brands. The business is organized into three reportable segments: U.S. Refreshment Beverages, U.S. Coffee, and International.

The company’s financial profile does not paint the picture of an unusually high-return franchise. Its net margin is 7.1% and its return on equity (ROE) is 5.6%—levels that suggest moderate profitability rather than a deep, capital-light moat. Those figures are consistent with a beverage operation that owns bottling, distribution, and coffee-brewing hardware assets: owning roughly 8,100 vehicles in the U.S. and 2,200 vehicles in Mexico for DSD and warehouse-direct routes is a competitive asset, but also a capital-intensive one. The breadth of the brand portfolio, plus the installed base of Keurig brewing systems and the recurring demand for K-Cup pods, does provide some pricing power and customer lock-in; however, the single-digit ROE indicates that pricing power is partly consumed by input costs, logistics, and brand-support spending. In short, KDP looks more like a scale-led, route-to-market player than a high-margin, asset-light brand owner.

Financial posture

At the time of the data snapshot, Keurig Dr Pepper had a market capitalization of $50.1 billion, a P/E ratio of 37.0, and a share price of $36.82. That P/E multiple is materially above what its 7.1% net margin and 5.6% ROE would normally support in a purely profitability-based model, so the market is clearly pricing in something beyond current earnings—likely the stability of the non-alcoholic beverage category, the company’s planned separation into two public companies, and the pending JDE Peet’s transaction.

Defensive characteristics are also visible: the stock carries a beta of 0.41, well below the market average, implying far less day-to-day volatility than the broad equity market. The stock is also technically extended, with an RSI of 75.5 and a 50-day EMA of $32.90 versus the current $36.82 price. That gap simply tells readers that the shares have run ahead of their moving average; it is not a directional recommendation.

Strategic priorities & outlook

The company’s most recent 10-K outlines a clear set of near-term priorities:

The planned JDE Peet’s acquisition and subsequent split is the most consequential strategic item. If completed, it would remake KDP’s structure and could alter how investors value the coffee operations versus the refreshment-beverage business. Until those deals close, however, they represent event risk as well as potential catalysts. The operational emphasis on productivity is also notable because ingredients and packaging represented approximately 55% of cost of sales, including green coffee, aluminum cans and ends, PET bottles and caps (including rPET), sweeteners, and K-Cup pod packaging. Any improvement in procurement efficiency or logistics utilization therefore has direct profit-and-loss impact.

Macro & geopolitical exposure

As a North American non-alcoholic beverage company, Keurig Dr Pepper’s exposures map closely to the Consumer Defensive staples playbook. Key macro factors include:

Recent developments

Recent headlines have centered on the upcoming third-quarter report and product innovation:

The timing is notable because Q3 2026 earnings are scheduled for 2026-11-03 before the market open, with an analyst consensus EPS estimate of $0.618. The Alta launch may come up as management’s evidence of innovation, while the 247wallst.com piece highlights how investors often evaluate this name through a dividend-stability lens.

Earnings behavior & post-earnings drift

Keurig Dr Pepper has an unusually strong earnings track record on the headline beat metric. Over the last eight reported quarters it beat the consensus estimate in 7 out of 8 quarters (100% if excluding the single miss) and posted an average earnings surprise of 3.2%. Yet execution has not translated into reliable short-term price gains.

Across the same period, the average 5-day price move after earnings was -2.01%, classified as a downward post-earnings drift. That pattern means that even when results top estimates, the stock has tended to soften over the following week. The most recent quartet illustrates the mix:

One interpretation is that the company reliably clears the official consensus but that the unofficial expectation, guidance commentary, and valuation already embed good news. With the next report scheduled for before the open on November 3, 2026, and the consensus at $0.618, traders may want to watch management commentary on input costs, JDE Peet’s closing timing, and volume trends rather than just the beat/miss headline.

Frequently Asked Questions

What does Keurig Dr Pepper actually sell?

It is a North American non-alcoholic beverage company selling hot and cold beverages plus single-serve brewing systems across more than 125 owned, licensed, and partner brands, organized into U.S. Refreshment Beverages, U.S. Coffee, and International segments.

How has the stock typically reacted after earnings?

KDP has beaten the consensus in 7 of the last 8 quarters with an average earnings surprise of 3.2%, yet the average 5-day post-earnings move has been -2.01%, indicating a tendency toward post-report price softness.

What are the biggest risks from a macro perspective?

The main exposures are commodity inputs—green coffee, aluminum, PET/rPET, caps, sweeteners, and K-Cup packaging—along with environmental regulation on plastics, labor agreements, and customer concentration, with Walmart accounting for roughly 16% of 2025 net sales.

For a deeper dive into institutional sentiment, valuation models, and consensus expectations around the upcoming report, review the full institutional verdict on the ticker page rather than relying on summary figures alone.

Real Data - Gamma QC Earnings IntelligenceAs of Nov 2, 2026
Keurig Dr Pepper Inc. · Consumer Defensive / Beverages - Non-Alcoholic
$50.1BMarket cap
37.0P/E
7.1%Net margin
5.6%ROE
100%Beat rate, last 8Q
3.2%Avg EPS surprise
-2.01%Avg 5-day move after earnings
2026-11-03Next earnings
ReportedActualEstimateSurprise1D Move5D Move
2026-08-06$0.57$0.537+6.1%-1.19%+2.47%
2026-04-23$0.39$0.3724+4.7%+2.42%+3.05%
2026-02-24$0.6$0.589+1.9%-2.84%-4.71%
2025-10-27$0.54$0.537+0.6%-1.3%-8.86%
2025-07-24$0.49$0.4853+1%--
2025-04-24$0.42$0.3824+9.8%--

Previous KDP editions

Beyond the primer

Get the institutional verdict on KDP

Seven-seat 21-ERT council. Pre-print forecast signed before the earnings release. Post-print grade, published in public. Every verdict sealed with a cryptographic receipt.

Read the KDP verdict at Gamma QC
$49 Pro / $249 RIA * gammaqc.com

Verify authenticity

Every Gamma QC verdict is signed with a cryptographic receipt at issuance. Independently verify any published verdict at attest.gammaqc.com. This educational primer is content-only and not itself signed; the institutional verdict at the link above is.